Author: OurCrowd

[MeMed in Molecular Diagnostics Europe] Redefining the Set of Solutions for Antibiotics Misuse Using Host Response-Based Diagnostics

Dr. Kfir Oved outlines some of the greatest obstacles to controlling antibiotic misuse, advice for introducing new products in the clinical setting, describes some of the most exciting new developments emerging for AMR, and summarizes what he is looking forward to at the Advanced Diagnostics for Infectious Disease track at Molecular Diagnostics Europe Summit. Read more on Molecular Diagnostics...

Read More

[PRESS RELEASE] OurCrowd Launches Our Network – Matching World’s Biggest Companies with Israel’s Most Exciting Startups

Jerusalem –  June 22, 2017 –  OurCrowd, a global leader in equity crowdfunding, today announced the launch of OurNetwork – a new collaboration program leveraging OurCrowd’s global network, providing multinationals with the ability to stay ahead of the latest innovation trends globally by providing access to Israel’s bustling tech startup community. Read more...

Read More

[OurCrowd in The Times of Israel] OurCrowd adds Andy Kaye to team as president & CIO

Andy Kaye, a veteran of the finance industry, has joined Jerusalem-based OurCrowd as president and chief institutional officer. Kaye will work closely with OurCrowd founder and CEO Jon Medved in Jerusalem to help boost growth at the firm, the crowdfunding venture capital fund said in a statement. Kaye has over 20 years of experience in the finance industry, working with some of the global investment banks. He has held positions at Robertson Stephens, as Israel CEO and head of two European industry groups, as well as at CIBC, where he was regional head of their investment banking operation in Israel. Kaye most recently spent five years in China as head of Asia for William Blair, followed by two years in London as managing director of EMEA Tech for Blair. Read more on The Times of Israel...

Read More